Aastrom Biosciences, Inc. (ASTM) to Participate in Noble Financial Capital Markets' BioX Life Sciences Exposition
9/19/2012 9:25:08 AM
ANN ARBOR, Mich., Sept. 19, 2012 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that company president and CEO Tim Mayleben will participate in the Advancements in Cell Therapy & Regenerative Medicine discussion at the Noble Financial Capital Markets' BioX Life Sciences Exposition. The discussion will take place on Monday, September 24, 2012 at 11:45 a.m. at the University of Connecticut, Stamford Campus.
comments powered by